{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:27:24Z","timestamp":1786544844130,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08381-7","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:35:12Z","timestamp":1784979312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel perspective on biomarkers of neurodegeneration and neuroinflammation in first episode psychosis: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Valeria","family":"Zakurazhnaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-2717","authenticated-orcid":false,"given":"Yana","family":"Zorkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Abramova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Riabinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ochneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriya","family":"Ushakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy P.","family":"Kostyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"8381_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.59249\/OAMT2710","volume":"96","author":"D Pav\u0103l","year":"2023","unstructured":"Pav\u0103l D, et al. The Importance of Cerebrospinal Fluid Investigation in First-episode Psychosis. Yale J Biol Med. 2023;96:125\u20136.","journal-title":"Yale J Biol Med"},{"key":"8381_CR2","doi-asserted-by":"crossref","unstructured":"Soares W, de Lima O. A. Advances in neuroscience, neuropsychiatry, and neurology: first episode of psychosis: from psychosis continuum to specialized treatment. United States (US): IGI Global. 2024:65-87.","DOI":"10.4018\/979-8-3693-0851-6.ch005"},{"key":"8381_CR3","doi-asserted-by":"publisher","first-page":"115475","DOI":"10.1016\/j.psychres.2023.115475","volume":"328","author":"L Inchausti","year":"2023","unstructured":"Inchausti L, Gorostiza I, Gonzalez Torres MA, Oraa R. The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use. Psychiatry Res. 2023;328:115475.","journal-title":"Psychiatry Res"},{"key":"8381_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1192\/bjp.bp.117.201475","volume":"211","author":"J Lally","year":"2017","unstructured":"Lally J, et al. Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry. 2017;211:350\u20138.","journal-title":"Br J Psychiatry"},{"key":"8381_CR5","doi-asserted-by":"publisher","first-page":"s120","DOI":"10.1192\/bjp.187.48.s120","volume":"48","author":"International Early Psychosis Association Writing Group","year":"2005","unstructured":"International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry. Suppl 2005;48:s120\u2013124.","journal-title":"Br J Psychiatry"},{"key":"8381_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/wps.20446","volume":"16","author":"P Fusar-Poli","year":"2017","unstructured":"Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry. 2017;16:251\u201365.","journal-title":"World Psychiatry"},{"key":"8381_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13416","volume":"146","author":"C Dunleavy","year":"2022","unstructured":"Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand. 2022;146:6\u201320.","journal-title":"Acta Psychiatr Scand"},{"key":"8381_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.tics.2017.06.006","volume":"21","author":"JK Forsyth","year":"2017","unstructured":"Forsyth JK, Lewis DA. Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features. Trends Cogn Sci. 2017;21:760\u201378.","journal-title":"Trends Cogn Sci"},{"key":"8381_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2183\/pjab.95.014","volume":"95","author":"K Obi-Nagata","year":"2019","unstructured":"Obi-Nagata K, Temma Y, Hayashi-Takagi A. Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model. Proc Jpn Acad Ser B Phys Biol Sci. 2019;95:179\u201397.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"8381_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00441-020-03226-5","volume":"382","author":"M Zagrebelsky","year":"2020","unstructured":"Zagrebelsky M, Tacke C, Korte M. BDNF signaling during the lifetime of dendritic spines. Cell Tissue Res. 2020;382:185\u201399.","journal-title":"Cell Tissue Res"},{"key":"8381_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/brainsci12040414","volume":"12","author":"S Singh","year":"2022","unstructured":"Singh S, Roy D, Marzouk T, Zhang J-P. Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis. Brain Sci. 2022;12:414.","journal-title":"Brain Sci"},{"key":"8381_CR12","first-page":"185","volume":"42","author":"O Pino","year":"2014","unstructured":"Pino O, et al. Neurodevelopment or neurodegeneration: review of theories of schizophrenia. Actas Esp Psiquiatr. 2014;42:185\u201395.","journal-title":"Actas Esp Psiquiatr"},{"key":"8381_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.schres.2022.03.004","volume":"243","author":"WS Stone","year":"2022","unstructured":"Stone WS, et al. Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophr Res. 2022;243:154\u201362.","journal-title":"Schizophr Res"},{"issue":"2","key":"8381_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/ijms25021030","volume":"25","author":"D Potashnikova","year":"2024","unstructured":"Potashnikova D, Maryukhnich E, Vorobyeva D, Rusakovich G, Komissarov A, Tvorogova A, Gontarenko V, Vasilieva E. Cytokine Profiling of Plasma and Atherosclerotic Plaques in Patients Undergoing Carotid Endarterectomy. Int J Mol Sci. 2024;25(2):1030. https:\/\/doi.org\/10.3390\/ijms25021030. PMID: 38256102; PMCID: PMC10816498.","journal-title":"Int J Mol Sci"},{"key":"8381_CR15","doi-asserted-by":"crossref","unstructured":"Blazevic N, et al. YKL-40 as a biomarker in various inflammatory diseases: a review. Biochem Med (Zagreb). 2024:34.","DOI":"10.11613\/BM.2024.010502"},{"issue":"1","key":"8381_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/XCE.0000000000000073","volume":"5","author":"ND Mygind","year":"2016","unstructured":"Mygind ND, Axelsson A, Ruwald MH, et al. The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test. Cardiovasc Endocrinol. 2016;5(1):21\u20137. https:\/\/doi.org\/10.1097\/XCE.0000000000000073.","journal-title":"Cardiovasc Endocrinol"},{"key":"8381_CR17","doi-asserted-by":"publisher","unstructured":"Zhao X, Tang R, Gao B, Shi Y, Zhou J, Guo S, Zhang J, Wang Y, Tang W, Meng J, Li S, Wang H, Ma G, Lin C, Xiao Y, Feng G, Lin Z, Zhu S, Xing Y, Sang H, St Clair D, He L. Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet. 2007;80(1):12\u2009\u2013\u20098. https:\/\/doi.org\/10.1086\/510438.\u00a0Epub 2006 Nov 13. PMID: 17160890; PMCID: PMC1785314.","DOI":"10.1086\/510438"},{"issue":"2","key":"8381_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biopsych.2007.12.012","volume":"64","author":"MS Yang","year":"2008","unstructured":"Yang MS, Morris DW, Donohoe G, Kenny E, O\u2019Dushalaine CT, Schwaiger S, Nangle JM, Clarke S, Scully P, Quinn J, Meagher D, Baldwin P, Crumlish N, O\u2019Callaghan E, Waddington JL, Gill M, Corvin A. Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism. Biol Psychiatry. 2008;64(2):98\u2013103. Epub 2008 Feb 20. PMID: 18281018.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"8381_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/pcn.13848","volume":"79","author":"S Hidese","year":"2025","unstructured":"Hidese S, Hattori K, Enokida T, Tatsumi M, Matsumura R, Kunugi H. Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample. Psychiatry Clin Neurosci. 2025;79(8):488\u201395. https:\/\/doi.org\/10.1111\/pcn.13848. Epub 2025 Jun 6. PMID: 40476607.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"8381_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.62641\/aep.v52i4.1672","volume":"52","author":"X Pan","year":"2024","unstructured":"Pan X, Su W, Wang Z, Jin X, Chen Z, Jin H, Chen H. Correlations between Immunoinflammatory Factor Levels and Cognitive Functions and Brain Structural Magnetic Resonance Imaging Features among Patients with Primary Schizophrenia. Actas Esp Psiquiatr. 2024;52(4):464\u201373. https:\/\/doi.org\/10.62641\/aep.v52i4.1672. PMID: 39129687; PMCID: PMC11319761.","journal-title":"Actas Esp Psiquiatr"},{"issue":"1","key":"8381_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/acps.12971","volume":"139","author":"I Dieset","year":"2019","unstructured":"Dieset I, M\u00f8rch RH, Hope S, Hoseth EZ, Reponen EJ, Gran JM, Aas M, Michelsen AE, Reichborn-Kjennerud T, Nesv\u00e5g R, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA. An association between YKL-40 and type 2 diabetes in psychotic disorders. Acta Psychiatr Scand. 2019;139(1):37\u201345. https:\/\/doi.org\/10.1111\/acps.12971. Epub 2018 Oct 17. PMID: 30328100.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"8381_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/acps.12944","volume":"138","author":"F Orhan","year":"2018","unstructured":"Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, Flyckt L, Farde L, Sellgren CM, Piehl F, Karolinska Schizophrenia Project (KaSP) Consortium, Engberg G, Erhardt S. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis. Acta Psychiatr Scand. 2018;138(5):432\u201340. https:\/\/doi.org\/10.1111\/acps.12944. Epub 2018 Aug 21. PMID: 30132802.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"8381_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12291-022-01068-2","volume":"38","author":"N Keshri","year":"2023","unstructured":"Keshri N, Nandeesha H. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian J Clin Biochem. 2023;38(1):4\u201312. https:\/\/doi.org\/10.1007\/s12291-022-01068-2. Epub 2022 Jul 25. PMID: 36684500; PMCID: PMC9852406.","journal-title":"Indian J Clin Biochem"},{"key":"8381_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.schres.2017.06.011","volume":"192","author":"H An","year":"2018","unstructured":"An H, Zhou L, Yu Y, Fan H, Fan F, Tan S, Wang Z, Shi ZB, Yang J, Zhang F, Tan X, Huang Y. Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls. Schizophr Res. 2018;192:457\u20138. Epub 2017 Jun 16. PMID: 28624138.","journal-title":"Schizophr Res"},{"key":"8381_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpsychires.2020.09.012","volume":"131","author":"H An","year":"2020","unstructured":"An H, Qin J, Fan H, Fan F, Tan S, Wang Z, Shi J, Yang F, Tan Y, Huang XF. Decreased serum NCAM is positively correlated with hippocampal volumes and negatively correlated with positive symptoms in first-episode schizophrenia patients. J Psychiatr Res. 2020;131:108\u201313. Epub 2020 Sep 14. PMID: 32950707.","journal-title":"J Psychiatr Res"},{"key":"8381_CR26","doi-asserted-by":"publisher","unstructured":"Vawter MP, Hemperly JJ, Freed WJ, Garver DL. CSF N-CAM in neuroleptic-na\u00efve first-episode patients with schizophrenia. Schizophr Res. 1998;34(3):123\u2009\u2013\u200931. Erratum in: Schizophr Res 2001;51(2\u20133):187. https:\/\/doi.org\/10.1016\/s0920-9964(98)00103-0.\u00a0 PMID: 9850978.","DOI":"10.1016\/s0920-9964(98)00103-0"},{"key":"8381_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12291-020-00937-y","volume":"37","author":"N Keshri","year":"2022","unstructured":"Keshri N, Nandeesha H, Rajappa M, Menon V. Relationship Between Neural Cell Adhesion Molecule-1 and Cognitive Functioning in Schizophrenia Spectrum Disorder. Indian J Clin Biochem. 2022;37:494\u20138.","journal-title":"Indian J Clin Biochem"},{"issue":"7","key":"8381_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.30773\/pi.2017.11.10","volume":"15","author":"CS Chu","year":"2018","unstructured":"Chu CS, Li DJ, Chu CL, Wu CC, Lu T, Decreased. IL-1ra and NCAM-1\/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment. Psychiatry Investig. 2018;15(7):727\u201332. https:\/\/doi.org\/10.30773\/pi.2017.11.10. Epub 2018 Jun 15. PMID: 29898582; PMCID: PMC6056701.","journal-title":"Psychiatry Investig"},{"key":"8381_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","volume":"46","author":"G Favalli","year":"2012","unstructured":"Favalli G, Li J, Belmonte-de-Abreu P, Wong AHC, Daskalakis ZJ. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res. 2012;46:1\u201311.","journal-title":"J Psychiatr Res"},{"key":"8381_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2014.01.012","volume":"51","author":"SL Chen","year":"2014","unstructured":"Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, Wang TY, Chen PS, Lee IH, Yang YK, Hong JS, Lu RB. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:99\u2013104. Epub 2014 Jan 25. PMID: 24468644; PMCID: PMC7137229.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8381_CR31","doi-asserted-by":"publisher","unstructured":"Koeva YA, Sivkov ST, Akabaliev VH, Ivanova RY, Deneva TI, Grozlekova LS, Georgieva V. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients. Folia Med (Plovdiv). 2014 Jan-Mar;56(1):20\u2009\u2013\u20093. https:\/\/doi.org\/10.2478\/folmed-2014-0003. PMID: 24812918.","DOI":"10.2478\/folmed-2014-0003"},{"key":"8381_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2018.02.034","volume":"263","author":"L Man","year":"2018","unstructured":"Man L, Lv X, Du XD, Yin G, Zhu X, Zhang Y, Soares JC, Yang XN, Chen X, Zhang XY. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia. Psychiatry Res. 2018;263:1\u20136. Epub 2018 Feb 15. PMID: 29482040.","journal-title":"Psychiatry Res"},{"key":"8381_CR33","doi-asserted-by":"publisher","unstructured":"Chen DC, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, Li YL, Wang N, Yang KB, Xiu MH, Kosten TR, Zhang XY. Decreased levels of serum brain-derived neurotrophic factor in drug-na\u00efve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl). 2009;207(3):375\u2009\u2013\u200980. https:\/\/doi.org\/10.1007\/s00213-009-1665-6. Epub 2009 Sep 29. PMID: 19787338.","DOI":"10.1007\/s00213-009-1665-6"},{"issue":"22","key":"8381_CR34","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.3390\/ijms232214498","volume":"23","author":"A Ochneva","year":"2022","unstructured":"Ochneva A, Zorkina Y, Abramova O, et al. Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders. Int J Mol Sci. 2022;23(22):14498. https:\/\/doi.org\/10.3390\/ijms232214498. Published 2022 Nov 21.","journal-title":"Int J Mol Sci"},{"key":"8381_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, et al. TDP-43 Pathology in Alzheimer\u2019s Disease. Mol Neurodegener. 2021;16:84.","journal-title":"Mol Neurodegener"},{"issue":"Pt 10","key":"8381_CR36","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1093\/brain\/awv220","volume":"138","author":"RH Tan","year":"2015","unstructured":"Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C, Forrest SL, Affleck A, Kwok JB, Hodges JR, Kiernan MC, Halliday GM. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain. 2015;138(Pt 10):3110\u201322. https:\/\/doi.org\/10.1093\/brain\/awv220. Epub 2015 Jul 31. PMID: 26231953.","journal-title":"Brain"},{"key":"8381_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","volume":"138","author":"I Kawakami","year":"2019","unstructured":"Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 2019;138:751\u201370. https:\/\/doi.org\/10.1007\/s00401-019-02077-x.","journal-title":"Acta Neuropathol"},{"key":"8381_CR38","doi-asserted-by":"publisher","first-page":"698571","DOI":"10.3389\/fnagi.2021.698571","volume":"13","author":"C Zecca","year":"2021","unstructured":"Zecca C, Pasculli G, Tortelli R, Dell\u2019Abate MT, Capozzo R, Barulli MR, Barone R, Accogli M, Arima S, Pollice A, Brescia V, Logroscino G. The Role of Age on Beta-Amyloid1-42 Plasma Levels in Healthy Subjects. Front Aging Neurosci. 2021;13:698571. https:\/\/doi.org\/10.3389\/fnagi.2021.698571. PMID: 34531734; PMCID: PMC8438760.","journal-title":"Front Aging Neurosci"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08381-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:28:13Z","timestamp":1786541293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08381-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8381"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08381-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the recommendations of the Helsinki Declaration. The study protocols were approved by the Local Ethics Committee of Mental Health Clinic No. 1 named after N. A. Alekseev of the Department of Health of Moscow (Protocol No. 2\/28 October 2020).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"615"}}